Cancer Genetics CD-ROM for Hispanics
Interactive CD-ROM on Cancer Genetics for Hispanics
This project will build upon prior, successful research on the effectiveness of an interactive computer disk with readable only memory (CD-ROM) for educating women about breast cancer and genetic risk. Prior studies found that an interactive CD-ROM for educating women about breast cancer risk and genetic testing was effective. The program was well received by lay persons and professionals. In a randomized controlled trial conducted at multiple sites, the CD-ROM intervention was highly effective in increasing knowledge, especially among women at low risk of carrying a breast cancer susceptibility gene 1/2 (BRCA1/2) mutation.
Researchers now propose to expand the use of the interactive CD-ROM in two innovative ways. The overall goal of this proposal is to evaluate the program as a first-line educational approach for Hispanic women on the Texas-Mexico border, where educational resources about cancer genetics are limited. First, researchers will modify and adapt the program for a primarily Hispanic population, in order to make it culturally and linguistically appropriate to the needs of that audience.
Second, researchers will evaluate the program as a first-line educational method among women with a personal or family history of breast cancer. Researchers will compare the effectiveness of the CD-ROM when implemented with and without the guidance of a trained promotora, and in comparison with standard educational materials (usual care condition).
The specific aims of this study include:
Aim 1: To modify the interactive CD-ROM to: a) make it culturally and linguistically appropriate for Hispanic women residing along the Texas-Mexico border; b) reflect current knowledge about breast cancer genetics; c) add a module to help women prepare to discuss their family history and cancer risk with a health care provider (n=50 participants).
Aim 2: To conduct a randomized, controlled evaluation that compares the efficacy of the modified CD-ROM when used alone vs. when used with a promotora-assisted approach vs. standard written materials (n=414 participants).
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This study will test ways to help improve Hispanic women's knowledge and understanding about breast cancer risk and genetic testing for inherited cancer risk. These methods include providing printed educational materials, using an educational computer program, and using the computer program with the assistance of a lay health worker (a promotora).
If you agree to take part in this study, you will complete a questionnaire that will ask about your personal health as well as your knowledge and attitudes toward cancer and genetic testing. After the questionnaire is completed, you will be randomly assigned (as in the roll of dice) to 1 of 3 study groups. One group will be asked to read educational materials. Another group will use an educational computer program to learn about breast cancer risk and genetic testing without guidance. Another group will use the computer program with the guidance of a promotora.
Each of the 3 study groups should take between 30 and 60 minutes to complete.
Immediately after participating in your assigned group, you will be asked to complete another questionnaire that will ask about your knowledge and attitudes toward cancer and genetic testing. You will also be contacted later by telephone to complete similar questionnaires at about 1 month and 6 months after your study visit. Some women will be asked to complete an additional questionnaire by telephone 1 week after reading the educational materials or the computer program, and researchers will ask for permission to audiotape this interview. It will take about 20 minutes to complete each of the questionnaires used in this study.
This is an investigational study. Up to 414 women will take part in this study.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Texas
-
El Paso, Texas, Vereinigte Staaten, 79905
- The Cancer and Chronic Disease Consortium (CCDC) of El Paso
-
Houston, Texas, Vereinigte Staaten, 77030
- UT MD Anderson Cancer Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Residing in the El Paso metropolitan area and self-identifying as Hispanic
- Being 18 years of age or older
- Women who have a personal history of breast cancer or have a first-degree relative with breast cancer OR lay health workers (male or female)
- Able to provide informed consent
Exclusion Criteria:
- Having a primary language other than English or Spanish
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Group 1: Written Materials
One group asked to read educational materials.
|
Focus group discussion lasting about 60 to 90 minutes.
Printed materials will be given.
The CD-ROM will be offered at the end of the study.
Occasional questionnaire, written or verbal phone survey, about knowledge and attitudes toward cancer and genetic testing.
Andere Namen:
|
|
Experimental: Group 2: Computer Program Only
Group 2 use an educational computer program to learn about breast cancer risk and genetic testing without guidance.
|
Focus group discussion lasting about 60 to 90 minutes.
Occasional questionnaire, written or verbal phone survey, about knowledge and attitudes toward cancer and genetic testing.
Andere Namen:
Participants will be given a program to learn about breast cancer risk and genetic testing. Arm 3 Only = Participants will use the program with the assistance of a promotora (female "promoter," community health worker, sometimes known as a lay health advisor). |
|
Experimental: Group 3: Computer Program + Promotora
Group 3 use the computer program with the guidance of a promotora.
|
Focus group discussion lasting about 60 to 90 minutes.
Occasional questionnaire, written or verbal phone survey, about knowledge and attitudes toward cancer and genetic testing.
Andere Namen:
Participants will be given a program to learn about breast cancer risk and genetic testing. Arm 3 Only = Participants will use the program with the assistance of a promotora (female "promoter," community health worker, sometimes known as a lay health advisor). |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Data analysis of structured questionnaires
Zeitfenster: 3 Years
|
3 Years
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Comparison of 3 Intervention Groups by Continuous Outcomes (knowledge, risk assessment, decisional conflict and quality of life)
Zeitfenster: 3 Years
|
3 Years
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Susan Peterson, PhD, M.D. Anderson Cancer Center
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2006-0339
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Brustkrebs
-
Novartis PharmaceuticalsAbgeschlossenMetastasierter Brustkrebs (MBC) | Locally Advance Breast Cancer (LABC)Vereinigtes Königreich, Spanien
-
BioNTech SESeventh Framework ProgrammeAbgeschlossenBrustkrebs (Triple Negative Breast Cancer (TNBC))Schweden, Deutschland
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RekrutierungBrustkrebs | HER2-positiver Brustkrebs | Invasiver Brustkrebs | Entzündlicher Brustkrebs Stadium III | HER2 Low Breast AdenokarzinomVereinigte Staaten
Klinische Studien zur Focus Group
-
Prince of Songkla UniversityAbgeschlossenKolorektale Neubildungen | Kolorektaler PolypThailand
-
Hui-Hsun ChiangAbgeschlossenErziehungsprobleme | Pflege | Gewalt am ArbeitsplatzTaiwan
-
Umeå UniversityNoch keine RekrutierungHüftfrakturen | Anästhesie | Hämodynamische Instabilität | Echokardiographie | Risikoabschätzung
-
University of WashingtonPatient-Centered Outcomes Research InstituteNoch keine RekrutierungSchizophrenie | Bipolare Störung | Depression | Schizoaffektiven Störung
-
University of California, Los AngelesAbgeschlossenDepression | Stress, Psychisch | Belastungsstörungen, traumatisch | Angst | Emotionaler Stress | Trauma, Psychisch | Verhalten, Kind | Regulierung, Selbst
-
Washington University School of MedicineStryker NordicRekrutierungKnie ArthroseVereinigte Staaten
-
Nantes University HospitalUnbekannt
-
University of MichiganNational Cancer Institute (NCI); Wayne State University; Barbara Ann Karmanos... und andere MitarbeiterAbgeschlossenBrustkrebs | Darmkrebs | Lungenkrebs | ProstatakrebsVereinigte Staaten
-
Brown UniversityKeitner/Family Therapy Research GrantAbgeschlossenBrustkrebs | Sexuelle Funktionsstörung | ProstatakrebsVereinigte Staaten
-
University of California, Los AngelesAktiv, nicht rekrutierendDepression | Stress, Psychisch | Belastungsstörungen, traumatisch | Angst | Eltern-Kind-Beziehungen | Erziehung | Emotionaler Stress | Bewältigungsfähigkeiten | Emotionsregulation | Trauma, Psychisch | Verhalten, KindVereinigte Staaten